Age at onset predicts risk of rapid myopic progression

Columbus, OH—In children with juvenile myopia, younger age at onset appears to be associated with an increased risk for rapid progression of refractive error, said Karla Zadnik, OD, PhD.

Related Videos
Related Content

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023

Nanoscope Therapeutics announces positive topline results from Phase 2b RESTORE trial of MCO-010 for treatment of retinitis pigmentosa

March 31st 2023

Podcast: Talking about the anterior segment pipeline for 2023

March 29th 2023

Retinal scans show eyes as a window to track aging

March 31st 2023

The importance of ocular health prior to cataract and refractive surgery

February 28th 2023

American Academy of Ophthalmology rallies against expanding prior authorization to Medicare Fee For Services

March 30th 2023

Lotilaner ophthalmic solution an effective, safe treatment for Demodex blepharitis

March 30th 2023
© 2023 MJH Life Sciences

All rights reserved.